Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient
Ann Hematol
.
2019 Jan;98(1):227-230.
doi: 10.1007/s00277-018-3421-7.
Epub 2018 Jul 6.
Authors
Clemens Hinterleitner
1
,
Martina Steurer
1
,
Daniela Dörfel
1
,
Jonas Heitmann
1
,
Klaus-Peter Kreisselmeier
1
,
Karin Müller
2
,
Hans-Georg Kopp
1
,
Stefan Wirths
1
,
Michael Haap
3
,
Leticia Quintanilla-Martinez de Fend
4
,
Marius Horger
5
,
Carlos Rodriguez-Galindo
6
,
Lothar Kanz
1
,
Martin R Müller
7
8
Affiliations
1
Department of Oncology, Hematology and Immunology, University of Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
2
Department of Cardiology, University of Tübingen, Tübingen, Germany.
3
Department of Endocrinology, Diabetology, Clinical Pathology and Metabolism, University of Tübingen, Tübingen, Germany.
4
Department of Pathology and Neuropathology, University of Tübingen, Tübingen, Germany.
5
Department of Radiology, University of Tübingen, Tübingen, Germany.
6
Department of Global Pediatric Medicine, St. Jude's Children Research Hospital, Memphis, TN, USA.
7
Department of Oncology, Hematology and Immunology, University of Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
[email protected]
.
8
Department of Oncology, Hematology and Immunology, Klinikum Siloah, Hannover, Germany.
[email protected]
.
PMID:
29980874
DOI:
10.1007/s00277-018-3421-7
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Adult
Clofarabine / administration & dosage*
Histiocytosis, Sinus / diagnosis
Histiocytosis, Sinus / drug therapy*
Histiocytosis, Sinus / pathology
Humans
Male
Remission Induction
Salvage Therapy
Substances
Clofarabine